Compound 539
Identifiers
- Canonical SMILES:
CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](C)N)C(C)C)C(N)=O
- IUPAC name:
N-(1-amino-3-methyl-1-oxopentan-2-yl)-1-[2-(2-aminopropanoylamino)-3-methylbutanoyl]pyrrolidine-2-carboxamide
- InChi:
InChI=1S/C19H35N5O4/c1-6-11(4)15(16(21)25)23-18(27)13-8-7-9-24(13)19(28)14(10(2)3)22-17(26)12(5)20/h10-15H,6-9,20H2,1-5H3,(H2,21,25)(H,22,26)(H,23,27)/t11-,12-,13-,14-,15-/m0/s1
- InChiKey:
JHPFUTHPFNABKY-YTFOTSKYSA-N
External links
23646361 |
CHEMBL365059 |
23252139 |
External search
Bibliography (1)
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
1 | 0 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
XIAP / Smac | 6.24 | cancer | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 397.27 g/mol | |||
HBA | 9 | |||
HBD | 6 | |||
HBA + HBD | 15 | |||
AlogP | -0.50 | |||
TPSA | 147.62 | |||
RB | 9 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 1 | 0 | 0 | 0 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.9362 | Cyclo(prolylglycyl) | DB04541 | |
0.8958 | acetylleucyl-leucyl-norleucinal | DB07558 | |
0.7797 | Rapastinel | DB11801 | |
0.7797 | Dusquetide | DB11879 | |
0.7708 | Pramiracetam | DB13247 | |
0.7667 | Larazotide | DB05645 | |
0.7647 | Brivaracetam | DB05541 | |
0.7500 | Verpacamide A | DB04433 | |
0.7377 | NNZ-2591 | DB15601 | |
0.7292 | Valrocemide | DB06657 | |
0.7097 | Sinapultide | DB11332 | |
0.7083 | Etiracetam | DB11868 | |
0.7083 | Levetiracetam | DB01202 | |
0.7077 | Glypromate | DB05633 | |
0.7077 | Trofinetide | DB06045 |